论文部分内容阅读
急性冠脉综合征(acute coronary syndrome,ACS)为冠脉粥样硬化斑块破裂、继发血栓形成导致冠状动脉血流减少,经皮冠脉介入治疗虽然改善了冠脉血流但是人体整个冠脉粥样硬化进程仍在继续,而血脂的异常与动脉粥样硬化斑块关系密切。本文选用丹蒌片对痰瘀互阻型NSTEACS患者的治疗,探讨其对NSTEACS患者介入术后血脂和心功能的影响。1资料与方法1.1诊断标准西医诊断标准:根据2011ACCF/
Acute coronary syndrome (ACS) is a ruptured coronary atherosclerotic plaque. Secondary thrombosis leads to decreased coronary blood flow. Although percutaneous coronary intervention improves coronary blood flow, the entire coronary body Atherosclerosis continues, and abnormalities in blood lipids are closely related to atherosclerotic plaques. In this paper, the use of Dan tablets in the treatment of patients with phlegm and blood stasis type of resistance NSTEACS, to explore the impact of NSTEACS patients after interventional blood lipids and cardiac function. 1 Materials and Methods 1.1 Diagnostic criteria Western diagnostic criteria: According to 2011ACCF /